Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$13.13
$12.06
$7.19
$15.23
$51.60B0.55890,891 shs529,560 shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$263.43
+1.6%
$242.71
$164.23
$269.43
$624.12B0.248.12 million shs6.35 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.53
-1.9%
$25.11
$23.11
$28.75
$139.86B0.3541.06 million shs28.88 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
0.00%-4.86%+16.81%+17.23%+54.65%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.58%+4.15%+9.21%+15.82%+55.86%
Pfizer Inc. stock logo
PFE
Pfizer
-1.99%-2.21%+1.98%-9.19%-3.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$13.13
$12.06
$7.19
$15.23
$51.60B0.55890,891 shs529,560 shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$263.43
+1.6%
$242.71
$164.23
$269.43
$624.12B0.248.12 million shs6.35 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.53
-1.9%
$25.11
$23.11
$28.75
$139.86B0.3541.06 million shs28.88 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
0.00%-4.86%+16.81%+17.23%+54.65%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.58%+4.15%+9.21%+15.82%+55.86%
Pfizer Inc. stock logo
PFE
Pfizer
-1.99%-2.21%+1.98%-9.19%-3.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
3.13
BuyN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.80
Moderate Buy$265.300.71% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.19
Hold$28.5016.21% Upside

Current Analyst Ratings Breakdown

Latest PFE, JNJ, and BAYRY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Reiterated RatingBuy$270.00
7/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeOutperformBuy$280.00
7/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Reiterated RatingOutperform$305.00
7/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetOutperform$258.00 ➝ $265.00
7/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Set Price Target$261.00
7/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Reiterated RatingBuy$282.00
7/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetOverweight$284.00 ➝ $294.00
7/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetOverweight$263.00 ➝ $272.00
7/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UpgradeHoldStrong-Buy
7/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Set Price Target$260.00
7/13/2026
Pfizer Inc. stock logo
PFE
Pfizer
Lower Price TargetOutperform$34.00 ➝ $30.00
(Data available from 7/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$51.55B1.00$2.18 per share6.02$7.50 per share1.75
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B6.73$14.35 per share18.36$33.85 per share7.78
Pfizer Inc. stock logo
PFE
Pfizer
$63.31B2.21$4.31 per share5.69$15.26 per share1.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
-$4.10B-$0.64N/A9.954.21-4.75%17.61%4.81%8/4/2026 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6330.5220.582.4621.48%32.86%13.41%10/13/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3118.728.61N/A11.83%19.44%8.41%8/4/2026 (Estimated)

Latest PFE, JNJ, and BAYRY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026N/A
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$0.23N/AN/AN/A$12.31 billionN/A
8/4/2026Q2 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.68N/AN/AN/A$14.43 billionN/A
7/15/2026Q2 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.84$2.90+$0.06$2.27$25.06 billion$25.31 billion
5/12/2026Q1 2026
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$0.64$0.79+$0.15$0.82$15.77 billion$15.73 billion
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
$0.020.15%N/AN/A N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.362.03%+5.25%62.11%64 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.727.01%-13.20%131.30%16 Years

Latest PFE, JNJ, and BAYRY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.17%8/25/20268/25/20269/8/2026
6/24/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.01%7/24/20267/24/20269/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
1.06
1.05
0.70
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.46
1.03
0.77
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94

Institutional Ownership

CompanyInstitutional Ownership
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bayer Aktiengesellschaft stock logo
BAYRY
Bayer Aktiengesellschaft
88,0783.93 billionN/ANot Optionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Lido Advisors LLC Sells 141,542 Shares of Pfizer Inc. $PFE
Traders Buy High Volume of Pfizer Call Options (NYSE:PFE)
Pfizer (NYSE:PFE) Shares Down 1.9% - Here's What Happened

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bayer Aktiengesellschaft stock logo

Bayer Aktiengesellschaft OTCMKTS:BAYRY

$13.13 0.00 (0.00%)
As of 07/24/2026 03:59 PM Eastern

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$263.43 +4.16 (+1.60%)
Closing price 07/24/2026 03:59 PM Eastern
Extended Trading
$263.30 -0.13 (-0.05%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Pfizer stock logo

Pfizer NYSE:PFE

$24.52 -0.49 (-1.94%)
Closing price 07/24/2026 03:59 PM Eastern
Extended Trading
$24.54 +0.01 (+0.04%)
As of 07/24/2026 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.